VOR BIOPHARMA INC's ticker is VOR and the CUSIP is 929033108. A total of 61 filers reported holding VOR BIOPHARMA INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $15,610 | +308.9% | 15,610 | +869.0% | 0.00% | – |
| Q1 2024 | $3,818 | -68.1% | 1,611 | -69.7% | 0.00% | – |
| Q4 2023 | $11,959 | -64.0% | 5,315 | -66.1% | 0.00% | -100.0% |
| Q3 2023 | $33,244 | +412.3% | 15,681 | +646.7% | 0.00% | – |
| Q2 2023 | $6,489 | +3672.7% | 2,100 | -91.9% | 0.00% | -100.0% |
| Q4 2022 | $172 | -99.9% | 25,881 | -44.5% | 0.01% | +133.3% |
| Q3 2022 | $186,000 | +73.8% | 46,660 | +116.9% | 0.00% | +50.0% |
| Q2 2022 | $107,000 | -43.4% | 21,512 | -31.2% | 0.00% | 0.0% |
| Q1 2022 | $189,000 | -12.1% | 31,274 | +69.5% | 0.00% | -50.0% |
| Q4 2021 | $215,000 | +1854.5% | 18,450 | +2427.4% | 0.00% | – |
| Q3 2021 | $11,000 | -35.3% | 730 | -21.7% | 0.00% | – |
| Q2 2021 | $17,000 | -5.6% | 932 | +117.2% | 0.00% | – |
| Q1 2021 | $18,000 | – | 429 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 6,692,429 | $124,814,000 | 31.41% |
| Trustees of Columbia University in the City of New York | 183,821 | $3,428,000 | 5.06% |
| RA Capital Management | 11,120,973 | $207,406,000 | 3.33% |
| Johnson & Johnson Innovation - JJDC, Inc. | 1,074,658 | $20,042,000 | 2.05% |
| Sarissa Capital Management LP | 707,010 | $13,186,000 | 1.05% |
| SECTORAL ASSET MANAGEMENT INC | 405,324 | $7,559,000 | 0.61% |
| Woodline Partners LP | 1,146,494 | $21,382,000 | 0.40% |
| Artal Group S.A. | 550,000 | $10,258,000 | 0.21% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 50,000 | $933,000 | 0.20% |
| Orbimed Advisors | 833,333 | $15,542,000 | 0.16% |